Currently out of the existing stock ratings of Mitchell Kapoor, 77 are a BUY (93.9%), 5 are a HOLD (6.1%).

Mitchell Kapoor

Work Performance Price Targets & Ratings Chart

Analyst Mitchell Kapoor works with a stock forecast success ratio of 25.51% fulfilled within 32.64 days on average. Previously, Mitchell Kapoor worked at HC WAINWRIGHT.

Mitchell Kapoor’s has documented 159 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on LEGN, Legend Biotech Corp at 14-May-2024.

Wall Street Analyst Mitchell Kapoor

Analyst best performing recommendations are on LEGN (LEGEND BIOTECH CORP).
The best stock recommendation documented was for LEGN (LEGEND BIOTECH CORP) at 4/18/2023. The price target of $66 was fulfilled within 3 days with a profit of $13.76 (26.34%) receiving and performance score of 87.8.

Average potential price target upside

IMGO Imago Biosciences IPSC Century Therapeutics LEGN Legend Biotech Corp LYEL Lyell Immunopharma RAIN Rain Therapeutics RANI Rani Therapeutics Holdings TYRA Tyra Biosciences HALO Halozyme Therapeutics RLYB Rallybio Corp RPHM Reneo Pharmaceuticals TIL Instil Bio .

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

36

$-0.01 (-0.03%)

36

1 years 5 months 20 days ago

3/3 (100%)

$0.35 (0.98%)

267

Hold

36

$-0.01 (-0.03%)

35

1 years 5 months 26 days ago

3/4 (75%)

$0.4 (1.12%)

145

Hold

36

$-0.01 (-0.03%)

1 years 5 months 26 days ago

1/1 (100%)

$0.4 (1.12%)

48

Hold

36

$-0.01 (-0.03%)

30

1 years 5 months 26 days ago

2/2 (100%)

$0.4 (1.12%)

258

Hold

36

$-0.01 (-0.03%)

25

1 years 5 months 27 days ago

2/2 (100%)

$0.41 (1.15%)

37

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mitchell Kapoor is most bullish on?

Potential upside of $40.84 has been obtained for LEGN (LEGEND BIOTECH CORP)

Which stock is Mitchell Kapoor is most reserved on?

Potential downside of -$0.25 has been obtained for RPHM (RENEO PHARMACEUTICALS)

What Year was the first public recommendation made by Mitchell Kapoor?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?